Company GINO BIOW Nasdaq
Equities
DNA
US37611X1000
Biotechnology & Medical Research
Business Summary
Number of employees: 1,218
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Cell Engineering
57.1
%
| 144 | 30.1 % | 144 | 57.1 % | -0.09% |
Biosecurity
42.9
%
| 334 | 69.9 % | 108 | 42.9 % | -67.69% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 478 | 100.0 % | 251 | 100.0 % | -47.36% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Austin Che
FOU | Founder | - | 01/08/01 |
Founder | - | 01/08/01 | |
Reshma Shetty
FOU | Founder | 43 | 01/08/01 |
Jason Kelly
FOU | Founder | 43 | 01/08/01 |
Mark Dmytruk
DFI | Director of Finance/CFO | 53 | 16/21/16 |
Steven Coen
AUD | Comptroller/Controller/Auditor | 58 | 15/23/15 |
Karen Tepichin
LAW | General Counsel | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Christian Henry
BRD | Director/Board Member | 56 | 16/21/16 |
Marijn Dekkers
CHM | Chairman | 65 | 16/21/16 |
Kathy Hannan
BRD | Director/Board Member | 62 | 02/22/02 |
Harry Sloan
BRD | Director/Board Member | 74 | 16/21/16 |
Jason Kelly
FOU | Founder | 43 | 01/08/01 |
Reshma Shetty
FOU | Founder | 43 | 01/08/01 |
Director/Board Member | 51 | 16/21/16 | |
Shyam Sankar
BRD | Director/Board Member | 42 | 16/21/16 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 120,000,000 | 0 | 0 | 66.98 % |
Stock B | 10 | 404,337,677 | 0 | 22,851,000 ( 5.651 %) | |
Stock C | 1 | 1,765,736,109 | 1,533,858,052 ( 86.87 %) | 114,827,000 ( 6.503 %) |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
11,535,246 | 2.58% | 1,580,329 $ | |
SYNLOGIC, INC. 3.63% | 422,720 | 3.63% | 756,669 $ |
Company contact information
Ginkgo Bioworks Holdings, Inc.
27 Drydock Avenue 8th floor
02210, Boston
+
http://www.ginkgobioworks.comSector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |